These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9573798

  • 1. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response.
    Kohler JJ, Pathangey LB, Brown TA.
    Oral Microbiol Immunol; 1998 Apr; 13(2):81-8. PubMed ID: 9573798
    [Abstract] [Full Text] [Related]

  • 2. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.
    Kohler JJ, Pathangey LB, Gillespie SR, Brown TA.
    Infect Immun; 2000 Jun; 68(6):3116-20. PubMed ID: 10816452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.
    Kozarov E, Miyashita N, Burks J, Cerveny K, Brown TA, McArthur WP, Progulske-Fox A.
    Infect Immun; 2000 Feb; 68(2):732-9. PubMed ID: 10639440
    [Abstract] [Full Text] [Related]

  • 9. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.
    Pathangey L, Kohler JJ, Isoda R, Brown TA.
    Vaccine; 2009 May 05; 27(20):2707-11. PubMed ID: 19428883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y, Hajishengallis G, Michalek SM.
    Infect Immun; 2001 Apr 05; 69(4):2154-61. PubMed ID: 11254570
    [Abstract] [Full Text] [Related]

  • 12. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
    Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR.
    Infect Immun; 1999 Dec 05; 67(12):6249-56. PubMed ID: 10569734
    [Abstract] [Full Text] [Related]

  • 13. Expression and immunogenicity of a cloned Porphyromonas gingivalis hemagglutinin in Salmonella typhimurium.
    Dusek DM, Progulske-Fox A, Brown TA.
    Adv Exp Med Biol; 1995 Dec 05; 371B():1119-21. PubMed ID: 7502765
    [No Abstract] [Full Text] [Related]

  • 14. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
    Zhang P, Lewis JP, Michalek SM, Katz J.
    Vaccine; 2007 Aug 14; 25(33):6201-10. PubMed ID: 17629367
    [Abstract] [Full Text] [Related]

  • 15. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO, Luiz WB, Sbrogio-Almeida ME, Nishimura LS, Guth BE, Ferreira LC.
    Infect Immun; 2004 Nov 14; 72(11):6480-91. PubMed ID: 15501779
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
    Yuzawa S, Kurita-Ochiai T, Hashizume T, Kobayashi R, Abiko Y, Yamamoto M.
    FEMS Immunol Med Microbiol; 2012 Mar 14; 64(2):265-72. PubMed ID: 22066647
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis.
    Zhang P, Yang QB, Balkovetz DF, Lewis JP, Clements JD, Michalek SM, Katz J.
    Vaccine; 2005 Sep 15; 23(39):4734-44. PubMed ID: 15955601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.